Background Uveal melanomas can develop in the choroid, ciliary body and iris. In choroidal and ciliary body melanomas, specific chromosomal changes correlate with metastatic disease. Iris melanomas have a better prognosis than choroidal melanomas, and it would be interesting to know if they share chromosomal changes. In addition, iris melanomas might harbour UV-induced mutations of tumour suppressor genes, such as PTEN and CDKN2A. Methods Twenty iris melanomas were analysed for chromosome 1p, 3, 6, 8, 9p and 10q abnormalities using fluorescence in situ hybridisation. These results were correlated to clinical follow-up data using statistical analyses.
INTRODUCTION
Iris melanomas are the least common of uveal melanomas (<6%) and tend to present at a smaller size than posterior melanomas. 1 They can cause drainage blockage of the anterior chamber angle and secondary elevation of the intraocular pressure. They carry a better prognosis compared with other uveal melanomas with a metastatic rate of 0.5% at 3 and 7% at 10 years, respectively. 2 Melanocytic lesions of the iris are usually managed by a 'wait and see policy' with regular follow-ups to detect possible growth. Biomicroscopy, gonioscopy and measurements with the slit lamp are standard tests. Ancillary tests such as fluorescein angiography and ultrasound biomicroscopy are sometimes needed to assess growth more accurately. Iris melanomas can be treated by local excision, enucleation or radiotherapy. Metastases are more likely to develop in those patients who are older or with diffuse iris melanomas, compared with well-defined nodular melanomas. Other warning signs are tumour features of iris root location and ciliary body invasion with elevated intraocular pressure and extraocular extension. 3 The differential diagnosis of iris melanoma includes CoganeReese syndrome, nevus, melanocytoma, metastasis, adenoma, adenocarcinoma, cyst and pigment dispersion syndrome. 4 The favourable outcome of iris melanomas compared with choroidal and ciliary body melanomas is poorly understood. Determining the prognosis on only histological classification proved to be difficult. 5 Therefore, more accurate tests are needed. The different anatomical locations of the intraocular melanomas result in different microenvironments. Aqueous humour and vitreous contain various soluble factors that might influence cell growth. 6 Another differential factor is UV radiation. Its role in uveal melanoma is inconclusive, but arguably the iris is more exposed to the sun than the choroid.
7e13 While UV radiation might induce changes in the genome, intrinsic genetic differences may also play a role. 14 To further elucidate the genetic differences between choroidal and iris melanomas, the following study was performed. Twenty iris melanomas were analysed for chromosomal aberrations well known in choroidal and ciliary body melanomas, such as loss of chromosome 3 and gain of chromosome 8q, 15 in addition to common changes in skin melanomas, such as loss of 9p21 and 10q23 (regions that harbour the tumour suppressor genes CDKN2A and PTEN, respectively). 16 
MATERIALS AND METHODS
The research methodology followed the tenets of the Declaration of Helsinki. Informed consent was obtained for the use of human tissue from the patients. The research was approved by the local research ethics committee. All cases of iris melanomas were collected from the files from the departments of pathology in Rotterdam (1993 to 2009) and Leiden (1980 to 2009) and reviewed retrospectively. Cases that originated from the ciliary body were excluded as well as patients who had no available follow-up information. This resulted in 22 iris melanomas available for our study. Fluorescence in situ hybridisation (FISH) was unsuccessful in two cases.
The enucleation and biopsy specimens were fixed in standard 10%, buffered formalin for 24 h. They were embedded in conventional paraffin wax, and sections were cut at 5 mm. Sections were stained with H&E in order to obtain a histopathological diagnosis. The specimens were reviewed and classified according to the Jakobiec histopathological classification of iris melanocytic tumours 5 : group 1 melanocytosis, group 2 melanocytoma, group 3 epithelioid cell nevus, group 4 intrastromal spindle cell nevus, group 5 spindle cell nevus with surface plaque, group 6 borderline spindle cell nevus, group 7 spindle cell melanoma, group 8 mixed spindle and epithelioid cell melanoma, group 9 epithelioid cell melanoma.
Paraffin-embedded iris melanoma slides were used for FISH (chromosome 1p, 3, 6, 8, 9p and 10q). The pathologist located the tumour, and dual-colour FISH (digoxygenin and biotin labelled probes) was performed with the following probes: RP11-48E9 (1p36), RP11-522N9 (3p13), Pa3.5 (centromere 3), RP11-64F6 (3q25), RP11-356B3 (6p22), RP11-787I22 (6q21), RP11-24P4 (8p21), D8Z2 (centromere 8), RP11-88J22 (8q22), P1.063 (9p21) and PAC190D6 (10q23). 17 The concentration for centromeric probes was 5 ng per slide, and for BAC probes 50 to 75 ng per slide was used. As a control for aneuploidy a probe on chromosome 5 was used: RP11-1059N10 (5q12). The tissue sections were pretreated by dewaxing with xylene, permeabilising with sodium thyocyanate, proteolysis and denaturation. After hybridisation and washing, slides were counterstained with 4
9 ,6-diamidino-2-phenylindole and mounted in antifade solution (Dabco-Vectashield 1:1). The amount of scored nuclei depended on the size of the tumour, at least 50 nuclei and until a maximum of 200 nuclei were scored. Cut-off limits for deletion (>25% of the nuclei with one signal) or amplification (>10% of the nuclei with three or more signals) were adapted from own experiments and the available literature. 18 The primary endpoint for disease-free survival (DFS) was the time to development of metastatic disease, whereby death due to other causes was being censored. Statistical analyses were performed with SPSS software, release 15.0. Actuarial probabilities of DFS (with an event defined as development of metastatic disease or metastasis-related death) were estimated according to the KaplaneMeier method. To examine the possibility that other clinical, histopathological or chromosomal variations affected the prognosis, we performed a Cox proportional hazard analysis for each confounding variable. An effect was considered significant if the p value was 0.05 or less. The following factors were evaluated: age, cell type (spindle, mixed or epithelioid cell), Jakobiec classification, growth pattern (nodular, multiple nodules or diffuse), involvement of ciliary body, tumour invasion of the chamber angle and chromosomal aberrations (chromosomes 1, 3, 6p, 6q, 8q, 9p and 10q).
RESULTS

Tumour characteristics
Twenty iris melanomas were included in our study. The specimens were classified according to the Jakobiec histopathological classification of iris melanocytic tumours 5 : three borderline spindle cell nevi, four spindle cell melanomas, six mixed spindle and epithelioid cell melanomas and seven epithelioid cell melanomas (figure 1).
Fifteen melanomas grew in the chamber angle, resulting in secondary glaucoma in five cases caused by angle closure. Nine iris melanomas that spread into the angle also spread into the ciliary body, but primarily originated from the iris and in all of them epithelioid cells were present (table 1) .
Clinical data
The median age of the patients at the time of diagnosis was 62 years. Three patients had a trabeculectomy for glaucoma in their medical history (melanoma no 2, 9 and 14). Surgery or ruthenium plaque irradiation was chosen to treat the iris melanoma.
The median follow-up time was 42 months (range 2e204 months). Three patients died of metastases. One patient had been treated with a trabeculectomy 12 years earlier (histopathological diagnosis at that time: CoganeReese syndrome) and died of metastatic disease (melanoma no 9). The second patient presented with metastases, located in the bones and submandibular lymph nodes, 3 years after a trabeculectomy (histopathological diagnosis at that time: iris nevus without signs of malignancy) (melanoma no 1). The third patient died of liver metastases 3 years after the iris melanoma, treated by Ruthenium plaque irradiation, recurred. This recurrence was treated by enucleation (melanoma no 13).
Another patient presented with liver metastases 2.3 years after enucleation as the primary treatment of her iris melanoma (melanoma no 10).
FISH results
All 20 iris melanoma tissue slides could be hybridised with the chromosome 3p and centromere 3 probe. For the other FISH probes, it was not always possible to obtain data, because often the material was too sparse to give a definite answer. See table 2 for the results.
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Three melanomas in our group were spindle cell nevi with borderline malignancy (Jakobiec group 6). Interestingly, two of them did not have any chromosomal aberrations, but the third one did lose one copy of chromosome 3q and 9p simultaneously with gain of chromosome 8q.
Statistical analysis
Univariate analysis was performed for all parameters, showing a lower DFS for patients with diffuse growing melanomas (p¼0.01), melanomas that lost a copy of chromosome 3 (p¼0.03) or invading the ciliary body (p¼0.01). The other chromosomal aberrations did not show any significant correlations. In a multivariate Cox proportional hazard analysis including growth pattern, ciliary body involvement and chromosome 3, they all lost significance.
DISCUSSION
Our study reports on chromosomal abnormalities in the largest group of iris melanomas described thus far. We demonstrated that in iris melanomas (partial) loss of chromosome 3 tends to occur often, in 9/20 tumours (45%), but only correlates with progressive disease in a univariate analysis. The frequency of chromosome 3 loss is almost similar to choroidal melanomas, in which case it strongly associates with patients at risk of metastatic disease. 19 Similar to common changes in skin melanomas, such as loss of 9p21 and 10q23, 7/20 iris melanomas (35%) revealed loss of chromosome 9p. UV radiation induces mutations in the CDKN2A gene that encodes for the p16 protein that acts as a negative regulator of the cell cycle and is located on chromosome 9p21. 20 Alterations of chromosome 9 occur frequently in cutaneous melanomas and relate to progressive disease. Conversely, CDKN2A mutations are rarely observed in UM. 24 25 Our results indicate a difference between iris and posterior melanomas, because loss of 9p is found in 7/20 iris melanomas.
Yet, we could not demonstrate aberrations of chromosome 10q in iris melanomas. Previously, it has been reported that the tumour suppressor gene PTEN (located on chromosome 10q) is not involved in uveal melanomas, whereas mutations of PTEN are present in up to 40% of cutaneous melanomas. 24e26 The same holds true for N-ras mutations. Mutations of the N-ras gene, located on chromosome 1p13, correlate with sunlight exposure and occur frequently in cutaneous melanoma arising in sun-exposed areas. 7 Nevertheless, N-ras mutations are usually absent in uveal melanomas, further questioning the role of sunlight in the pathogenesis of uveal melanoma. 8 15 In 8/20 iris melanomas, the ciliary body was invaded by tumour cells, and four of these tumours spread systemically. Ciliary-body involvement was only found to be a significant prognostic parameter in univariate analysis.
Little is known about somatic mutations and chromosomal aberrations in iris melanomas. To date, only eight iris melanomas have been cytogenetically analysed and described worldwide. The first karyogram of an iris melanoma revealed extra copies of chromosomes 2, 7 and 18, and loss of chromosome 15. Additionally, rearrangements on chromosomes 8q, 4q, 12p and marker chromosomes were observed. 27 Sisley et al karyotyped three iris melanomas and did not find any specific chromosomal changes common to all tumours. Clonal abnormalities of chromosomes 3, 5, 6, 7, 8, 9, 12, 15, 17, 18, 19 and Y were found, and in one case a large number of marker chromosomes were observed.
14 They concluded that iris melanomas experience relatively high levels of chromosomal alterations compared with choroidal melanomas, which is perhaps reminiscent of cutaneous melanoma. The third study included four irises among other uveal melanomas that were analysed by comparative genetic hybridisation. 28 Gains of chromosome 6p and 8q were identified twice, and gains of chromosome 8p and 13q were identified once. One melanoma was completely diploid. These three studies did not identify critical chromosomal regions and, furthermore, the results were not compared with DFS.
In contrast, we observed involvement of chromosome 9p in seven tumours and loss of chromosome 3 in nine iris melanomas. These results suggest that the tumour suppressor gene CDKN2A, located on chromosome 9p, might play a role in iris melanomas, and requires analyses of the gene itself. The role of chromosome 3 loss in iris melanomas needs further investigation. The prognostic significance is not as strong as in choroidal melanomas, but possibly this is the result of the small sample size. The differences between choroidal and iris melanomas suggest that environmental influences such as UV radiation, aqueous and vitreous humour may contribute to the metastatic potential of the tumour. Figure 2 Fluorescence in situ hybridisation analysis of iris melanoma no 1, EOM 149, demonstrating two signals for the biotin probe (red signal) on chromosome 10q and one signal for the digoxenin probe (green signal) on chromosome 9p (A), and one signal for both bio and dig probes on chromosome 3 (B).
